The Clinical Core of the Duke-UNC Comprehensive Sickle Cell Center (CSCC) comprises facilities, personnel, scientific resources, and sickle cell disease (SCD) patient populations at the medical centers of both Duke and University of North Carolina at Chapel Hill. The CSCC currently has 1,388 SCD patients evenly split between pediatric and adult populations, with 812 clients having SS homozygous SCD. In addition, through the NC Consortium for Sickle Cell Disease, we are able to draw upon even more of the 3,000 SCD patients in NC for our research activities. The Clinical Core has four primary missions all of which require comprehensive and caring patient interaction: (1) Patient Care - Faculty and staff directly provide integrated, state-of-the-art, and comprehensive health care services to Center patients and their families in coordination with the Patient Service Core. Further, the Core ensures that each patient has access to new research protocols as they become available. (2) Support and Performance of Inter-center Clinical Trials. The Duke-UNC Comprehensive Clinical Center is committed to participationin the multi-center clinical trials conducted by the Comprehensive Sickle Cell Center network and our Clinical Core will provide the infrastructurefor such collaborative studies. The Center has extensive experience in these types of trials and will provide data coordinators to coordinate data entry and analysis with the NHLBI Statistics and Data Management Staff. (3) Support and Performance of Other Clinical Research - The Core will support and conduct the clinical research activities of each of the individual investigators of the Duke-UNC Sickle Ceil Center. Core personnel will help identify and recruit appropriate study subjects, obtain informed consent, reliable specimen collection, accurate data capture, and responsible, non-intrusive administrative services (4) Support for Basic and Translational Research: Core personnel will help identify appropriate study subjects, obtain informed consent, and obtain blood and biologic samples for use in basic research studies, as well as to provide corollary clinical data where required and approved by the IRB. The Clinical Core includes physicians, the Center's Scholar, physician extenders, nurses, social workers, and data coordinators at both constituent institutions, and each site provides both pediatric and adult services. Because they maintain a close relationship with each study subject and are fully knowledgeable about the research being conducted, the Core staff is ideally positioned to ensure the effective implementation of all Center-based and multi-center research projects. Leadership includes Dr. Russell Ware as PI of the Core, and Dr. Eugene P. Orringer as UNC Site Director who ensure quality of patient care. They and the clinician-scientistsin the Core meet regularly as the Intemal Advisory Committee (see Administrative Core) with the Center Director. The IAC acts as a forum to encourage intra-Center collaboration as well as address issues with individual research protocols so they may be addressed in a timely manner.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54HL070769-05
Application #
7407407
Study Section
Special Emphasis Panel (ZHL1)
Project Start
2007-04-01
Project End
2008-03-31
Budget Start
2007-04-01
Budget End
2008-03-31
Support Year
5
Fiscal Year
2007
Total Cost
$434,649
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Telen, Marilyn J; Afenyi-Annan, Araba; Garrett, Melanie E et al. (2015) Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival. Transfusion 55:1378-87
Rein, Lindsay Am; Sung, Anthony D; Rizzieri, David A (2013) New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation. Int J Hematol Oncol 2:
De Castro, Laura M; Zennadi, Rahima; Jonassaint, Jude C et al. (2012) Effect of propranolol as antiadhesive therapy in sickle cell disease. Clin Transl Sci 5:437-44
Thornburg, Courtney D; Calatroni, Agustin; Panepinto, Julie A (2011) Differences in health-related quality of life in children with sickle cell disease receiving hydroxyurea. J Pediatr Hematol Oncol 33:251-4
Fitzhugh, Courtney D; Lauder, Naudia; Jonassaint, Jude C et al. (2010) Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol 85:36-40
Thornburg, Courtney D; Calatroni, Agustin; Telen, Marilyn et al. (2010) Adherence to hydroxyurea therapy in children with sickle cell anemia. J Pediatr 156:415-9
Thornburg, Courtney D; Dixon, Natalia; Burgett, Shelly et al. (2009) A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 52:609-15
Ashley-Koch, Allison E; Elliott, Laine; Kail, Melanie E et al. (2008) Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 111:5721-6
Grann, Victor R; Ziv, Elad; Joseph, Cecil K et al. (2008) Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol 143:288-93
Zennadi, R; De Castro, L; Eyler, C et al. (2008) Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors. Transfus Clin Biol 15:23-8

Showing the most recent 10 out of 28 publications